A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.

Source:http://linkedlifedata.com/resource/pubmed/id/9647252

J. Immunol. 1998 Jul 1 161 1 421-9

Download in:

View as

General Info

PMID
9647252